B
Braidwell’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $113M | Buy |
3,605,029
+895,154
| +33% | +$28M | 3.86% | 5 |
|
|
2025
Q1 | $90.9M | Sell |
2,709,875
-204,089
| -7% | -$6.85M | 3.2% | 7 |
|
|
2024
Q4 | $114M | Buy |
2,913,964
+206,709
| +8% | +$8.1M | 3.39% | 6 |
|
|
2024
Q3 | $107M | Buy |
2,707,255
+146,682
| +6% | +$5.77M | 3.02% | 6 |
|
|
2024
Q2 | $99.8M | Buy |
2,560,573
+1,252,562
| +96% | +$48.8M | 3.13% | 7 |
|
|
2024
Q1 | $56.3M | Sell |
1,308,011
-339,300
| -21% | -$14.6M | 1.81% | 19 |
|
|
2023
Q4 | $75.9M | Sell |
1,647,311
-456,085
| -22% | -$21M | 2.79% | 8 |
|
|
2023
Q3 | $71.9M | Buy |
2,103,396
+275,043
| +15% | +$9.4M | 2.27% | 10 |
|
|
2023
Q2 | $70.4M | Sell |
1,828,353
-308,757
| -14% | -$11.9M | 2.3% | 13 |
|
|
2023
Q1 | $76.5M | Buy |
2,137,110
+589,000
| +38% | +$21.1M | 2.52% | 11 |
|
|
2022
Q4 | $61M | Buy |
+1,548,110
| New | +$61M | 2.05% | 14 |
|